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Multiple reaction monitoringThe articular cartilage of synovial joints ensures friction-free mobility and attenuates mechanical impact on the
joint during movement. These functions are mediated by the complex network of extracellular molecules
characteristic for articular cartilage. Zonal differences in the extracellular matrix (ECM) are well recognized.
However, knowledge about the precise molecular composition in the different zones remains limited. In the
present study, we investigated the distribution of ECMmolecules along the surface-to-bone axis, using quantita-
tive non-targeted as well as targeted proteomics.\
In a discovery approach, iTRAQ mass spectrometry was used to identify all extractable ECM proteins in the
different layers of a human lateral tibial plateau full thickness cartilage sample. A targetedMRMmass spectrom-
etry approach was then applied to verify these findings and to extend the analysis to four medial tibial plateau
samples.
In the lateral tibial plateau sample, the unique distribution patterns of 70 ECMproteins were identified, revealing
groups of proteins with a preferential distribution to the superficial, intermediate or deep regions of articular
cartilage. The detailed analysis of selected 29 proteins confirmed these findings and revealed similar distribution
patterns in the four medial tibial plateau samples.
The results of this study allow, for the first time, an overview of the zonal distribution of a broad range of cartilage
ECM proteins and open up further investigations of the functional roles of matrix proteins in the different zones
of articular cartilage in health and disease.
© 2014 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Articular cartilage is a highly specialized tissue that serves to
facilitate joint mobility and to withstand mechanical load on the joint
(Buckwalter and Mankin, 1998; Bhosale and Richardson, 2008). Its
extensive ECM has a unique composition to meet the specific needs of
the tissue (Mow et al., 1992). It consists mainly of collagens and heavilyric tags for relative and absolute
etry;MTP,medialtibialplateau;
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pen access article under the CC BY-Ncharged proteoglycans. A variety of non-collagenous matrix proteins
add to the complexity and is important for ECM assembly and tissue
maintenance (Heinegård, 2009; Schaefer and Schaefer, 2010).
The articular cartilage matrix is organized differently depending on
the distance from the chondrocyte but also depending on the depth
from the articular surface (Buckwalter and Mankin, 1998; Guilak et al.,
2006; Bhosale and Richardson, 2008; Mittelstaedt et al., 2011). Four
zones are distinguished morphologically from the articular cartilage
surface to the cartilage–bone interface (Kato et al., 1988; Buckwalter
and Mankin, 1998; Hunziker et al., 2002; Bhosale and Richardson,
2008; Fig. 1). The thin superficial zone is characterized by flattened
ellipsoid cells and thin collagen fibrils arranged parallel to the surface,
providing shear and tensile strength. The intermediate zone contains
spheroid-shaped cells and randomly arranged fibres. The deep zone is
rich in glycosaminoglycans and shows spheroid-shaped chondrocytes,
which are arranged in columns perpendicular to the surface (Youn
et al., 2006). The zone of calcified cartilage connects to the subchondral
bone (Redler et al., 1975; Hoemann et al., 2012).C-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1.Articular cartilage zones. Four zones can be distinguishedmorphologically in articular cartilage. The boxes represent the sample plugs taken from the lateral tibial plateau (LTP) and
the medial tibial plateau (MTP). The insert illustrates the cell distribution and the collagen fibril orientation across the full thickness cartilage.
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to the development of pathological conditions (Heinegård, 2009).
Mechanical injury or disturbances of tissuemaintenance, as for example
in osteoarthritis, may trigger cells to alter the ECM structure and thus
impair the mechanical strength of the tissue (Hunziker, 2002). To
understand pathological processes and allow more accurate diagnosis
and tailor-made therapy of joint diseases, it is important to know the
molecular composition of the tissues involved, including variations
between the different zones of the cartilage.
In the past, several studies have been undertaken to characterize
these zones with regard to structural organization (Hunziker et al.,
2002; Schumacher et al., 2002; Youn et al., 2006), and protein
localisation (Schumacher et al., 1994; DiCesare et al., 1995; Lorenzo
et al., 1998a; Pfister et al., 2001; Söder et al., 2002; Veje et al., 2003).
Generally, these studies focused on one or two components, due to
technical restrictions, and could therefore not provide a broad
overview. Recently, genomic (Fukui et al., 2008; Grogan et al., 2013)
and proteomic studies (Zhang et al., 2011; Cillero-Pastor et al., 2013)
were applied to investigate gene expression and protein distribution
patterns with a broader scope. Challenges with articular cartilage
proteomics include the scarce availability of healthy human articular
cartilage biopsies, the high degree of cross-linking between the ECM
molecules, and the difficulty in identifying low abundant proteins,
particularly in the presence of highly abundant proteins and proteogly-
cans such as collagens and aggrecan.
The aim of the present study was to quantitatively analyze extract-
able proteins in humanarticular cartilage to provide a detailed overview
of the protein distribution. This was achieved by first applying a
non-targeted mass spectrometry approach (iTRAQ technology)
and subsequently by analyzing protein distribution in detail using
a targeted approach (MRM technology; Fig. 2).
We found unique patterns of protein distribution throughout the
different zones of the articular cartilage. This detailed characterization
strengthens our understanding of articular cartilagematrix composition
and forms the basis for further investigations of key molecules in tissue
function, maintenance and pathology.
2. Results
2.1. Quantitative mass spectrometry—discovery approach
To test the feasibility of the study and to get an overview about the
extractable ECM proteins in articular cartilage, iTRAQ labeled protein
mixtures of the different depth zones of a LTP sample were analyzed
using Q-TOF tandem mass spectrometry. This discovery approachallowed the quantification of 277 proteins. The total protein list, includ-
ing the weighted average protein ratio (versus reference sample) for
each sample pool (pools 1–9) is presented in Supplementary
Table S1. Each iTRAQ set was run individually and analyzed separately
by calculating the sample-to-reference ratio. The number of peptide
ratio measurements for each identified protein varied from n = 1
(in a few instances listed in italics in Table 1 and Supplementary
Table S1) to approximately 100 for, e.g. collagen and fibronectin. To
focus the analysis on cartilage ECM proteins, a subset of 70 proteins
was selected (Table 1). Plasma proteins, membrane proteins and intra-
cellular proteinswere excluded (Supplementary Table S2). Additionally,
collagens except collagen type VIwere removed from the list. Due to the
high degree of cross-linking in collagens, except collagen type VI, these
molecules are poorly extracted and cannot be quantitatively analyzed.
Different distribution patterns of ECM proteins in the LTP sample were
found (Fig. 3). Several proteins showed a distinct preference for the
superficial region, e.g. asporin, tenascin-C and collagen type VI (Fig. 3a).
Others were found to be more abundant with increasing depth, e.g.
aggrecan (G1, G2 and G3 domains), hyaluronan and proteoglycan link
protein 1 (link protein) and chondroadherin (Fig. 3c). Some showed an
even distribution throughout the tissue, e.g. decorin and PRELP
(Fig. 3d). Only thrombospondin-1 and mimecan were found to be
enriched in the middle region (Fig. 3b).2.2. Data verification using MRM mass spectrometry
From the 70 cartilage ECM proteins identified by the iTRAQ
approach, 29 proteins of special interest in articular cartilage were
selected for analysis by the MRM technology (marked in Table 1). The
advantage of the MRM approach is that pre-optimized assays for
selected, unique peptides are used, which provides higher sensitivity.
Furthermore, we were able to measure the proteins using a single
chromatography step without prior ion-exchange chromatography
enabling us to instead take more data points across the cartilage
depth, thereby achieving enhanced detail in the protein distribution
patterns.
Quantitative analysis of the protein distribution in the LTP sample
via iTRAQ and MRM approaches resulted in similar protein distribution
patterns for all analyzed proteins (Fig. 3). After having established
the feasibility of the study, the MRM approach was now used for a
detailed analysis of protein distribution patterns in four MTP samples.
The MRM transition list and the quantitative data for each peptide,
allowing the quantification of the respective protein in the LTP and
the four MTP samples, are shown in Supplementary Table S3 and S4a-e.
Fig. 2. Overview of the samples and sample preparation. Schematic depiction of the sample plugs and the collected tissue fractions (each fraction containing 10 sections of 10 μm each)
collected by cryosectioning beginning at the articular surface. Grey boxes represent tissue extracts used formass spectrometry analysis. To test the feasibility of the study, extracts from the
same lateral tibial plateau (LTP) samplewere quantitatively analyzed using the iTRAQ labeling technology and the label-freeMRMapproach. Next, theMRMapproachwas used to identify
protein distribution patterns in four different medial tibial plateau (MTP) samples. A Toluidine blue-stained tissue section (cross-section) from a sample adjacent to the one used for
vertical sectioning of LTP52 is shown. Note the gradient in staining indicating differences in proteoglycan content. *, Sections which did not represent full area of the sample plug due
to technical difficulties, actual protein content might be underrepresented.
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In the four MTP samples (MTP36, MTP43, MTP46 and MTP65),
protein distribution patterns similar to the ones identified in the LTP
sample were found. For most proteins, the protein distribution pattern
of a given proteinwas similar in the fourMTP samples. For a limited num-
ber of proteins (fibronectin, versican, COMP and biglycan), no consistent
pattern could be established (Fig. 6g; Supplementary Table S4a-e.
2.3.1. Proteins in the superficial region
Proteins identified with a preferential distribution in the superficial
region of the samples were asporin, tenascin-C, thrombospondin-4
and perlecan (Fig. 4a) as well as dermatopontin, collagen alpha-1 (VI)
and collagen alpha-3 (VI; Supplementary Table S4a-e). These proteins
showed peak abundance within the uppermost 20% of the total tissue
depth (Table 2 and Supplementary Table S5). Below the zone of
maximum abundance, the protein content decreased rapidly towards
the deeper regions.
2.3.2. Proteins in the deep region
Aggrecan G1 domain (as well as the G2 and G3 domains), link
protein, chondroadherin and osteoadherin showed a marked increaseof protein content towards the deep region of the samples (Fig. 4b).
Further examples are matrix Gla protein, matrilin-3, osteonectin
(SPARC) and serin protease HTRA1 (Supplementary Table S4a-e).
These proteins showed highest abundance between 60% and 100% of
the tissue depth, often in the deepest layers (Table 2 and Supplementary
Table S5). An exception is aggrecan G1 domain in the MTP65 sample,
which peaked at a depth of 850 μm and then remained at an even
level throughout the deeper tissue. Interestingly, MTP43 stands in
sharp contrast to the other MTP samples since the abundance of several
proteins was found to decrease towards the deepest layers after a peak
at 60%–80% of the tissue depth.
2.3.3. Proteins in the intermediate region
Only mimecan and thrombospondin-1 were found to be enriched
in the middle part of the MTP samples (Fig. 5a). They showed highest
abundance between 20% and 35% of tissue depth (Table 2). These
proteins decreased towards the deeper layer, but not as much as the
predominantly superficial proteins.
2.3.4. Evenly distributed proteins
Lumican, fibromodulin, decorin and PRELP showed an even
distribution throughout the tissue (Fig. 5b). However, they seemed to
be less abundant in the most superficial layers.
Table 1
Filtered list on quantitative proteomics data of the LTP52 sample (iTRAQ).
The average ratios versus the reference sample are listed. The accession numbers are derived from the SwissProt database. The complete list of identified proteins is available in Supple-
mentary Table S1. Single peptide quantifications are shown in italics. Empty cells indicate no identification. Proteins marked in (a) were also measured via MRMmass spectrometry.
Protein name Accession (a) Pool 1 Pool 2 Pool 3 Pool 4 Pool 5 Pool 6 Pool 7 Pool 8 Pool 9
Aggrecan core protein P16112 0.11 0.12 0.23 0.27 0.42 0.64 1.24 0.89 1.76
Aggrecan G1 domain P16112 X 0.120 0.118 0.247 0.263 0.404 0.607 1.291 0.983 1.969
Aggrecan G2 domain P16112 X 0.057 0.085 0.148 0.289 0.449 0.677 1.215 0.787 1.484
Aggrecan G3 domain P16112 X 0.132 0.165 0.218 0.230 0.330 0.528 0.783 0.472 0.888
Alpha-1-antichymotrypsin P01011 2.30 2.20 3.70 0.96 0.19 0.08
Alpha-1-antitrypsin P01009 2.76 2.53 3.52 0.65 0.12 0.09 0.08 0.05 0.15
Angiogenin P03950 0.19 0.35 0.42 0.23 0.41 1.13 7.71 6.46 15.74
Apolipoprotein A-I P02647 5.08 4.00 4.96 1.00 0.30 0.24 0.16 0.15 0.46
Apolipoprotein D P05090 0.18 0.16 0.19 0.09 0.11 0.37
Asporin Q9BXN1 X 1.90 1.78 1.34 0.17 0.03 0.01 0.03 0.01 0.04
Biglycan P21810 X 0.39 0.54 0.89 0.49 0.43 0.50 0.66 0.39 0.75
Cartilage intermediate layer protein 1–1 O75339 X 0.05 0.04 0.03 0.04 0.04 0.04 0.23 0.24 0.50
Cartilage intermediate layer protein 1–2 O75339b X 0.12 0.14 0.12 0.09 0.16 0.26 0.53 0.40 0.85
Cartilage intermediate layer protein 2-1 Q8IUL8 x 0.19 0.02 0.08 0.07 0.01 0.19 0.24 0.14 0.45
Cartilage intermediate layer protein 2–2 Q8IUL8b X 0.15 0.19 0.34 0.22 0.19 0.22 0.27 0.19 0.35
Cartilage oligomeric matrix protein (COMP) P49747 X 0.51 0.49 0.61 0.27 0.31 0.44 0.79 0.58 1.12
Chondroadherin O15335 X 0.03 0.02 0.03 0.02 0.04 0.12 0.37 0.32 0.67
Clusterin P10909 0.28 0.25 0.38 0.92 0.52 0.99
Collagen alpha-1 (VI) chain P12109 X 1.11 0.59 0.63 0.19 0.08 0.05 0.08 0.07 0.10
Collagen alpha-2 (VI) chain P12110 0.97 0.47 0.49 0.17 0.08 0.06 0.06 0.04 0.08
Collagen alpha-3 (VI) chain P12111 x 0.98 0.48 0.51 0.14 0.06 0.05 0.08 0.05 0.09
Collagen (II) chondrocalcin P02458c 0.22 0.21 0.30 0.03 0.06 0.10 0.15 0.09 0.17
Collagen (II) N-propep P02458 0.10 0.09 0.15
C-type lectin domain family member 11A Q9Y240 0.27 0.40 0.32 0.00 0.19 0.17
C-type lectin domain family member 3A O75596 0.03 0.04 0.01 0.02 0.01 0.07 0.06 0.12
Decorin P07585 x 0.56 0.62 0.85 0.43 0.35 0.38 0.56 0.38 0.81
Dermatopontin Q07507 x 0.49 0.58 0.51 0.03 0.01 0.00 0.03 0.03 0.06
EGF-like repeat and discoidin I-like domain-containing p.3 O43854 0.28 0.30 0.47 0.38 0.38 0.40
Extracellular superoxide dismutase [Cu-Zn] P08294 0.51 0.63 0.91 0.29 0.13 0.10 0.09 0.10 0.17
Fibroblast growth factor-binding protein 2 Q9BYJ0 0.00 0.00 0.00 0.09 0.12 0.40 1.18 0.72 1.76
Fibromodulin Q06828 x 0.08 0.15 0.31 0.23 0.31 0.39 0.68 0.41 0.79
Fibronectin P02751 x 0.24 0.15 0.12 0.04 0.05 0.05 0.21 0.21 0.41
Fibulin-1 P23142 3.29 0.99 0.72
Galectin-1 P09382 0.66 0.60 0.53 0.27 0.30 0.29
Galectin-3 P17931 0.00 0.20 0.20
Hyaluronan and proteoglycan link protein 1 (link protein) P10915 x 0.04 0.06 0.16 0.24 0.28 0.40 0.61 0.30 0.64
Interalpha-trypsin inhibitor heavy chain H1 P19827 4.28 2.41 1.72
Lactadherin Q08431 0.10 0.10 0.15 0.10 0.08 0.12 0.22 0.14 0.29
Leukocyte cell-derived chemotaxin-2 O14960 0.11 0.09 0.17 0.07 0.14 0.50 1.53 1.04 2.37
Lubricin (Proteoglycan 4) Q92954 x 0.60 0.26 0.17 0.04 0.02 0.03 0.03 0.02 0.06
Lumican P51884 x 0.54 0.74 1.00 0.49 0.30 0.19 0.22 0.12 0.25
Lysozyme C P61626 0.06 0.03 0.04 0.07 0.10 0.29 1.38 1.43 3.56
Matrilin-1 P21941 0.07 0.07 0.08 0.01 0.02 0.02 0.02 0.02 0.05
Matrilin-3 O15232 x 0.12 0.01 0.05 0.07 0.24 0.44 0.60 0.21 0.32
Matrix Gla protein P08493 x 0.00 0.10 0.05 0.49 1.02 1.86
Metalloproteinase inhibitor 3 P35625 0.02 0.12 0.13 0.00 0.11 0.18 1.00 0.58 1.48
Mimecan P20774 x 0.75 1.03 1.52 0.85 0.58 0.36 0.19 0.07 0.13
Osteoadherin (Osteomodulin) Q99983 x 0.03 0.12 0.19
Osteonectin (SPARC) P09486 x 0.07 0.22 0.19 0.28 0.31 1.75
Osteopontin P10451 x 0.29 13.72 21.10
Perlecan P98160 x 0.82 0.54 0.37 0.07 0.01 0.07 0.00 0.06 0.13
Phospholipase A2, membrane associated P14555 0.11 0.11 0.15 0.44 1.24 6.33 6.33 8.46 21.1
Pleckstrin homology domain-containing family A6 Q9Y2H5 6.59 6.52 15.24
Procollagen C-endopeptidase enhancer 1 Q15113 2.70 2.01 4.67 1.46 1.45 1.14
Procollagen C-endopeptidase enhancer 2 Q9UKZ9 0.22 0.25 0.33 0.24 0.28 0.36 0.55 0.32 0.72
PRELP P51888 x 0.26 0.35 0.54 0.41 0.38 0.41 0.54 0.31 0.61
Protein S100-A9 P06702 0.31 0.22 0.36 0.19 0.33 1.26
Retinoic acid receptor responder protein 2 Q99969 0.01 0.43 0.57 0.56 1.05 1.68 3.34 2.51 6.34
Secreted frizzled-related protein 3 Q92765 0.23 0.25 0.42 0.22 0.25 0.24 0.61 0.33 0.81
Serine protease HTRA1 Q92743 x 0.81 0.47 0.38 0.14 0.11 0.19 0.50 0.34 0.69
SPARC-related modular calcium-binding protein 2 Q9H3U7 0.00 0.09 0.18 0.17 0.11 0.26 0.54 0.38 0.95
Stromelysin-1 P08254 8.01 7.21 11.28 3.89 1.30 0.67 0.41 0.10 0.38
Sushi repeat-containing protein SRPX2 O60687 0.27 0.44 0.43 0.16 0.15 0.12 0.25 0.16 0.30
Target of Nesh-SH3 Q7Z7G0 0.37 0.41 0.44 0.11 0.05 0.03 0.03 0.01 0.03
Tenascin-C P24821 x 3.23 2.42 1.49 0.25 0.05 0.02
Tenascin-X P22105 0.83 0.70 0.59 0.12 0.07 0.15 0.21 0.00 0.06
Tetranectin P05452 1.08 1.16 1.64 0.68 0.51 0.13 0.09 0.01 0.08
Thrombospondin-1 P07996 x 0.14 0.21 0.44 0.48 0.44 0.38 0.30 0.14 0.26
Thrombospondin-3 P49476 0.25 0.25 0.29
Thrombospondin-4 P35443 x 0.26 0.25 0.29 0.00 0.00 0.00 0.18 0.02 0.22
TGF-beta-induced protein ig-h3 Q15582 1.27 0.70 0.66 0.17 0.05 0.05 0.00 0.01 0.15
(continued on next page)
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Table 1 (continued)
Protein name Accession (a) Pool 1 Pool 2 Pool 3 Pool 4 Pool 5 Pool 6 Pool 7 Pool 8 Pool 9
TNF receptor superfamily member 11B O00300 0.04 0.02 0.06 0.08 0.03 0.12 0.11 0.04 0.10
Versican P13611 x 0.18 0.09 0.08 0.04 0.05 0.06 0.11 0.07 0.12
Vitronectin P04004 10.75 7.67 7.61 1.45 0.22 0.09
72 kDa type IV collagenase P08253 2.23 2.30 3.55
The numbers in italics represent quantification data originating from a single peptide.
38 C. Müller et al. / Matrix Biology 40 (2014) 34–452.3.5. Outlining cartilage tissue boundaries in the samples
In an attempt to set the identified protein distribution patterns in the
LTP and MTP samples into perspective, we analyzed the distribution
pattern of the superficial zone protein lubricin (Schumacher et al.,
1994), the bone protein osteopontin (Franzen and Heinegård, 1985;
Sodek et al., 2000) and several serum proteins (Fig. 6). In the LTP52
sample, lubricin was found to be confined to the most superficial
layer (Fig. 6a). Lubricin was also found in the superficial part of the
MTP samples (Fig. 6b). However, it is interesting to note that the
lubricin content showed a less pronounced decrease toward the deeper
layers in MTP43 and MTP65. Osteopontin was most prominently
detected in the deepest layers of the LTP52 sample (Fig. 6c) and the
MTP samples (Fig. 6d). However, considering the absolute peak area
instead of the normalized values, only very low levels of the protein
could be detected in the MTP43 sample (Fig. 6e), indicating that we
did not reach the calcified/mineralized zone for this sample. Similar
patterns were observed for osteonectin (SPARC; Supplementary Table
S4a-e). Serum proteins showed different penetrations into the tissue
depending on the molecular size (Fig. 6f). The smaller ones, alpha-1-
acid glycoprotein 1 and serum albumin, were found to be accumulated
in a depth of 500 μm of the LTP52 sample but were less present
in the deeper regions. The larger proteins, fibronectin and alpha-
2-macroglobulin, were found at high concentrations in the uppermost
layers and in the deepest layers. A bias in the analysis of protein
distribution patterns is introduced if proteins are present in the serum
infiltrating the cartilage as well as produced by chondrocytes, as in the
case of fibronectin. Interestingly, the fibronectin distribution patterns
differ between the different MTP samples (Fig. 6g).
3. Discussion
Using quantitative mass spectrometry, we established the distribu-
tion patterns of a broad range of ECM proteins in articular cartilage
(Supplementary Fig. S1a). This resulted in the identification of groups
of proteins being enriched in the superficial region in the uppermost
20% of total tissue depth, of proteins enriched in the intermediate region
between 20% and 35 % of total tissue depth and proteins enriched
between 60% and 100% of total tissue depth (Supplementary Fig. S1b).
These findings are in accordance with the long-established notion
of articular cartilage being a composite of different zones with distinct
molecular composition and functional roles. These roles include the
maintenance of a tear-resistant and lubricating joint surface, a shock-
absorbing and elastic matrix and a connection to the subchondral
bone.We do not yet fully understand the complex networks of proteins
required to achieve these tasks. A detailed mapping of molecular com-
positionwill form the basis for further studies onmolecular interactions
and functional properties of the different zones. In this study, we used
the term region (superficial, intermediate and deep, respectively), to
refer to proteins showing predominance in certain parts of the samples.
Future studies correlating our findings with morphological criteria
defining the established term cartilage zones will further increase the
understanding of articular cartilage biology.
Our study of four humanMTP samples revealed a subset of proteins
with predominance in the superficial parts of the samples. Proteins such
as asporin and tenascin-C showed strict confinement to the uppermost
20% of the samples (Fig. 4a; Table 2), while others such as perlecan and
collagen type VI were also present in deeper zones albeit to a lesserdegree (Fig. 4a; Supplementary Tables S4a-e and S5). The presence of
lubricin in the superficial zone has been established by several studies;
it is known to be produced by superficial chondrocytes to lubricate the
joint surface (Schumacher et al., 1994). The highest abundance of
lubricin in the superficial part of the samples confirmed that the
analyzed cartilage plugs had an intact joint surface and were sampled
in a correct way. However, it is interesting to note that the lubricin
abundance peaked in a region just below the most superficial layers in
MTP 36, 43 and 46. It should be mentioned that the very first fraction
of MTP36, 43 and 46 and the first two fractions of MTP65 contained
protein extracts of slightly incomplete tissue sections due to technical
difficulties in aligning the sample joint surface with the microtome
knife (Fig. 2). The actual protein content may thus be slightly under-
represented in these fractions. However, this does not explain why
several superficial proteins showed peaks in protein abundance just
underneath themost superficial layers since the lower levels of superfi-
cial region proteinswere seen also in subsequent, complete sections. An
interesting exception is the MTP65 sample, where these proteins were
found to be highest in the most superficial layers, as was the case in
the LTP52 sample. MTP65 was derived from the oldest donor, suggest-
ing that the superficial zone could be abraded in the older samples.
Differences in the protein distribution patterns could also indicate
variation between the individual samples. One might also take these
reflections into consideration for the proteins where no consistent
distribution pattern could be established since the variation between
the samples was too large (Supplementary Table S4a-e). However, the
distribution patterns of asporin, tenascin-C and thrombospondin-4 are
remarkably similar, which suggests a structural-functional relation of
these proteins in the superficial region. In the future, these established
techniques will be used to study age-related differences to elucidate
possible changes in protein distribution during aging.
The other distinct subset identified in our study consists of proteins
that are steadily increasing in abundance towards the deep part of the
tissue, e.g. aggrecan, link protein, chondroadherin and osteoadherin
(Fig. 4b; Supplementary Table S4a-e). Variations in proteoglycan
and glycosaminoglycan distribution in articular cartilage are well
established (Stockwell and Scott, 1967; Poole et al., 1982; Bayliss
et al., 1983). Our data of increasing aggrecan with tissue depth, shown
for all three domains G1, G2 and G3 in both the LTP and the MTP
samples, fits well with these studies. Another important observation is
that all the predominantly deep proteins showed an ultimate decrease
towards the deepest layers in the MTP43 sample, in contrast to the
other samples. However, it is interesting to note that the distribution
patterns of MTP43 are in good agreement with the other samples
down to 2200 μm.
To delineate the sample boundaries, we analyzed the distribution
pattern of the bone protein osteopontin (Fig. 6c,d). Osteopontin is
detected in high abundance only in the deepest part of most samples
(except for MTP43). This confirms that the deepest layers were reached
in these samples, i.e. the calcified zone and possibly upper parts of the
subchondral bone. Consequently, this means that no deep tissue areas
are missing in MTP36, 46 and 65. However, for unknown reasons, we
could only detect very low absolute levels of osteopontin in the much
thicker cartilage sample MTP43 (Fig. 6e). We conclude from this that
the deepest fractions contain proteins just from the beginning of the
calcified zone or the bone tissue and therefore that the analyzed sample
contains mainly cartilage tissue.
Fig. 3. Protein distribution patterns in the LTP sample. In a discovery approach using the iTRAQ technology, proteins with a preferential distribution to the superficial (a), intermediate
(b) or deep (c) region of the LTP sample were identified. Some proteins showed even (d) distribution throughout the sample. This was verified by analyzing the same extract using
the MRM approach. iTRAQ data (black circles) and MRM data (grey boxes) were normalized to 1 by division of each data point with the highest one for a given protein or peptide,
respectively.
39C. Müller et al. / Matrix Biology 40 (2014) 34–45Thickness variation in the tibia cartilage has been reported, as well
as correlation to the body weight and height of the donor (Ateshian
et al., 1991; Shepherd and Seedhom, 1999; Li et al., 2005). Ateshian
et al. investigated 12 human MTPs identifying a mean thickness of2.42 ± 0.61 mm (Ateshian et al., 1991). Our own experience (unpub-
lished data) is that the thickness at any specified site does vary between
individuals of similar age, although thinning with age is the general
pattern.
Fig. 4. Proteins enriched in the superficial or the deep region of theMTP samples. Proteinswith a preferential distribution in the superficial (a) or in the deep (b) region of theMTP samples
were quantified via MRMmass spectrometry. The peptide selected for theMRM assay is indicated for the respective protein. The MRMdata were normalized to 1 by division of each data
point with the highest one for a given peptide.
40 C. Müller et al. / Matrix Biology 40 (2014) 34–45It is interesting to note that asporin and chondroadherin showed
reversed distribution patterns throughout the tissue. The same contrary
pattern was observed when comparing different cartilage tissues with
each other (Önnerfjord et al., 2012). Asporin was found to be high in
the fibrocartilage of the meniscus in comparison to articular cartilage,
while chondroadherin was found to be low in the meniscus but highly
abundant in various articular cartilages. The functional aspects of this
observation are still unknown.
Someproteins, such as PRELP anddecorin,were fairly evenly distrib-
uted (Fig. 5b). However, they seem to be absent from the most super-
ficial layers, as observed for several proteins with predominance in the
uppermost 20% of the tissue. This might indicate a thus far unknown
complexity in a zone just underneath the most superficial layers,
which may be related to recent observations of distinct biophysical
properties in this region (Buckley et al., 2010). Interestingly, only
mimecan and thrombospondin-1 showed predominance in the middle
part of the MTP samples (Fig. 5a; Table 2). A hypothesis for explaining
the scarcity of proteins with predominance in the intermediate zonecould be that this zone shares basic structural and functional roles
with all zones in the articular cartilage. Consequently, the important
proteins for these functions would be the ones with a broad or even
distribution throughout the tissue, like the members of the small
leucine-rich repeat proteins, and the bulk of the different collagens.
Since these collagens are heavily cross-linked, they are not sufficiently
extracted with the methodology used in this study, except for collagen
type VI, and could not be analyzed. The cartilage intermediate protein
CILP 1-1 showed a discrepancy with the literature as it was enriched
in the deeper layers (LTP and MRM data in Supplementary Table S1
and S4a-e, respectively) and not in the intermediate zone (Lorenzo
et al., 1998a). The other variant, CILP 1-2, was more evenly distributed
in the MTP samples with the protein being somewhat more enriched
in the intermediate zone. The reason for these differences is yet
unknown but the current study involves tissue from a different joint,
i.e. tibial knee cartilage versus femoral head cartilage (Lorenzo et al.,
1998a). In support, a recent paper from our group shows that the
molecular composition varies among different joints (Önnerfjord et al.,
Table 2
Regions of maximum protein abundance for superficial, intermediate and deep proteins. Depicted is the depth, in percentage of total tissue depth (from 0% = most superficial data point
to 100% = deepest data point), at which a protein was found at maximum abundance (*). Proteins with predominance in the superficial part showed maximum abundance in the
uppermost 20% of theMTP samples, proteins with predominance in the intermediate part at 20%–35% of the tissue depth. Proteinswith predominance in the deep part showed in general
highest abundance in the lower 40% of the samples.
Superficial a) Intermediate b) Deep c)
Protein Sample * (%) Protein Sample * (%) Protein Sample * (%)
Asporin MTP36 18 Mimecan MTP36 27 Aggrecan G1 MTP36 100
MTP43 7 MTP43 30 MTP43 63
MTP46 18 MTP46 35 MTP46 100
MTP65 2 MTP65 20 MTP65 (38)
Tenascin-C MTP36 18 Thrombospondin-1 MTP36 27 Chondroadherin MTP36 92
MTP43 7 MTP43 30 MTP43 80
MTP46 18 MTP46 (18) MTP46 100
MTP65 7 MTP65 20 MTP65 100
Thrombospondin-4 MTP36 18 Link protein MTP36 (51)
MTP43 7 MTP43 63
MTP46 10 MTP46 100
MTP65 2 MTP65 100
Perlecan MTP36 18 Osteoadherin MTP36 92
MTP43 7 MTP43 63
MTP46 18 MTP46 100
MTP65 11 MTP65 100
a) max. abundance within uppermost 20% of tissue depth.
b) max. abundance between 20% and 35% of tissue depth.
c) max. abundance within 60%–100% of tissue depth.
Parentheses indicate samples where the region of maximum protein abundance differs from the other samples.
41C. Müller et al. / Matrix Biology 40 (2014) 34–452012). On the other hand, both the CILP 2 variants show more enrich-
ment in the intermediate zone.
Most previous studies on protein distribution patterns were based
on antibody-based technologies. Even though such studies can give aFig. 5. Proteins enriched in the intermediate region or evenly distributed in theMTP samples. Pr
with an even distribution (b) throughout the tissuewere quantified viaMRMmass spectrometr
data were normalized to 1 by division of each data point with the highest one for a given peptdetailed picture of protein localisation, they are often difficult to
perform and interpret since they require specific antibodies and the
accessibility of certain epitopes. The problemwith epitope availability re-
presents a common challenge when establishing immunohistochemistryoteinswith a preferential distribution to the intermediate region (a) of theMTP samples or
y. The peptide selected for theMRMassay is indicated for the respective protein. TheMRM
ide.
Fig. 6. Protein distribution patterns of lubricin, osteopontin and serum proteins. Lubricin was identified in the most superficial layers of the LTP52 by both the iTRAQ andMRM approach
(a). Similarly, a predominance of lubricin in the superficial regionwas found in the fourMTP samples usingMRM (b). Osteopontinwas identified in the deepest layers of the LTP52 by both
iTRAQ andMRM (c). Similarly, a predominance of osteopontin in the deep regionwas found in the fourMTP samples usingMRM (d). Absolute values of osteopontin abundance by MRM
showed a distinct increase of osteopontin content in the deepest layers inMTP36, 46, 65 and LTP52, but very low levels inMTP43 (e). Serum proteins analyzed in LTP52 showed different
distribution patterns according to theirmolecularweight (f). The serumand ECMproteinfibronectin showedheterogeneousdistribution patterns in the fourMTP samples (g). Thepeptide
selected for theMRMassay is indicated for the respective protein. MRMand iTRAQdata in (a), (b), (c), (d), (f) and (g) were normalized to 1 by division of each data point with the highest
one for a given peptide or peptide, respectively. MRM data in (e) shows absolute signal intensities. Open symbols in (c) indicate protein identification from one peptide only.
42 C. Müller et al. / Matrix Biology 40 (2014) 34–45or immunofluorescence assays. Especially in cartilage, where there is a
complex ECM with highly cross-linked macromolecules containing a
multitude of different polysaccharide side chains, it is difficult to ensure
efficient antibody penetration and epitope availability. This usually
requires extensive antigen retrieval methods, e.g. incubation with
proteolytic enzymes such as proteinase K or pepsin, incubation with
enzymes to remove proteoglycan side chains such as chondroitinase
ABC or heat-induced antigen retrieval using low or high pH buffer.
There is a risk that these methods in themselves might alter themolecular structure or even abolish the availability of certain epitopes.
Furthermore, quantification of an antibody-based staining is challenging.
Consequently, established antibody-based methods can give valuable
information but require extensive optimization and quality control for
each protein of interest. Mass spectrometry is regarded the state-
of-the-art technique for protein identification, avoiding problems
associated with antibody-based methods (Pecchini et al., 2012).
Proteins are extracted and proteolytically digested to create
peptides. These peptides are detected during mass spectrometry
43C. Müller et al. / Matrix Biology 40 (2014) 34–45and sophisticated methods for quantification have been established.
Depending on the length of the proteins, several peptides identifying
a certain protein are usually detected, thereby strengthening the
identification.
It needs to be stressed, however, that protein analysis using mass
spectrometry can only be performed on solubilized proteins. Covalently
cross-linked proteins, like the fibrillar collagens except collagen type VI,
are therefore not efficiently extracted. In a previous study, we investi-
gated the extractability of selected ECM proteins (Önnerfjord et al.,
2012). Aggrecan, asporin, chondroadherin and decorin showed an
extractability of ≥90% from tibial knee cartilage, COMP of ca. 65% and
lubricin of ca. 80%. An extraction efficiency of 100% cannot be reached
due to the high degree of cross-linking of cartilage ECMmolecules and
thereby trapping of molecules in the matrix. Nevertheless, we think
that conclusions about the relative distribution of proteins, comparing
different zones with each other, can be made. Even thoughwe detected
chains of fibrillar collagens, e.g. collagen I alpha 1 and alpha 2 chains
and collagen II alpha 1 chain (Supplementary Table S1) we chose not
to draw any firm conclusions from these data since the extraction
efficiency of, e.g. collagen II has been shown to be ≤10%. It is also
unknown what this extractable pool represents, e.g. it could be newly
synthesized collagen not incorporated into the matrix.
The MRM technology allows targeted quantitative proteomics
with high sensitivity and accuracy (Gillette and Carr, 2013). Mass
spectrometry and antibody-based methods might target different
parts of a protein. Methodological differences might explain discrep-
ancies between our study and previous reports. For example, we
found collagen type VI at high levels in the superficial layers, while
it has been reported from immunofluorescence studies to be located
throughout the articular cartilage, possibly to a lesser extent in the
superficial zone (Söder et al., 2002; Hansen et al., 2012; Wilusz
et al., 2013). This discrepancy may be explained by the epitope not
being exposed in the superficial zone, e.g. by interacting proteins
masking the binding site. Although our results may reflect more effi-
cient extraction from the superficial layers, most proteins discussed
in this study (including collagen type VI) were found to be extract-
able in a previous study on full thickness knee cartilage
(Önnerfjord et al., 2012). The observed distribution patterns of
tenascin-C enriched in the superficial zone match previous immuno-
histochemical investigations (Veje et al., 2003). The identified pat-
terns of distribution of several proteins match well with the gene
expression investigated in the different zones of a human lateral
femoral condyle in a study by Fukui et al. (2008). In this study, the
genes of chondroadherin, CILP, link protein and aggrecan showed
the highest expression in the deep cartilage region.
Articular cartilage is known to show inter- and intra-joint vari-
ability due to differences in mechanical load and architecture of the
joints (Buckwalter andMankin, 1998). Furthermore, even though ar-
ticular cartilage zones are distinguishedmorphologically, the bound-
aries cannot be sharply defined. Therefore, it is difficult to compare
structural studies with each other. In a quantitative study of the
structural organization of human, medial femoral cartilage by
Hunziker et al., the superficial zone was defined as the upper 10%,
the transitional zone as the next 10% and the middle zone as the re-
maining 80% until the tidemark (Hunziker et al., 2002). When apply-
ing our approach as presented here to other areas in the knee as well
as other joints, it will be possible to map structural differences and to
define the different zones of articular cartilage in amore precise way.
In the past, several studies focused on femoral condyle cartilage. We
chose to analyze protein distribution patterns in tibial plateau carti-
lage since this area has the least curvature to its shape and therefore
could be sectioned parallel to the joint surface in a reproducible
manner. In future studies, it would be interesting to compare tibial
and femoral cartilage of the opposing weight-bearing surfaces to
each other. Furthermore, future studies will focus on understanding
the functional importance of a distinct ECM composition in differentcompartments, for example, by relating the molecular composition
to biomechanical properties and cell distribution and metabolism.
This study provides a thus far unique overview of the ECM protein
distribution in articular cartilage. This will have implications in basic
research identifying structural-functional relations in cartilage ECM, as
well as clinical approaches in tissue repair and design. In addition,
comparing the protein distribution between healthy and pathological




Filter tubes (molecular weight cut-off, 30 kDa) were purchased
from PALL Life Sciences (Nanosep MI, USA). Reversed phase C18
(SUM-SS18V) spin columns were purchased from the Nest Group
(MA, USA). Crude synthetic peptides were purchased from JPT
(SpikeTides, JPT Peptide Technologies GmbH, Germany) and Thermo
(Thermo-Fisher Scientific, Germany). A peptide mixture was made
from the synthetic peptides (JPT) for checking system performance
and retention times were adjusted using a peptide mixture (iRT Kit
from Biognosys AG, Switzerland). Further reagents were described
before (Önnerfjord et al., 2012).
4.2. Sample preparation
4.2.1. Dissection, cryosectioning and extraction
Full-thickness macroscopically normal human articular cartilage
from LTP and MTP were used in this study. The LTP sample was used
to get an overview of the extractable proteins. The iTRAQ approach
was used here to identify protein patterns and based on that, MRM
assays for proteins of interest were established. Extracts from the
same sample were then used to confirm the identification of similar
protein patterns using the targeted and more sensitive MRM technolo-
gy. The scarce availability of healthy human cartilage samples is a
constant challenge in the field of cartilage research. For this reason,
we chose to perform the initial feasibility test, method optimization
and comparison between the two quantitative mass spectrometry
approaches on the single LTP sample we obtained. MTP samples, more
commonly associated with knee osteoarthritis (Felson et al., 2002),
were then used to perform MRM analysis on four samples from the
same joint region but from different individuals, thereby allowing
identification of inter-individual variation.
The LTP sample was obtained from a 52-year-old male (LTP52)
following amputation for bone tumours not involving the joint space
(within 18 h of amputation) from the Stanmore Musculoskeletal
BioBank following Research Ethics Committee approval (06/Q0506/
31). The cartilage was rinsed briefly in PBS to remove traces of blood
and synovialfluid and stored at−80 °C until itwasprocessed for exper-
iments. Four MTP samples from forensic medicine cases from 36, 43, 46
and 65-year-old males with no previous joint disease history (MTP36,
MTP43, MTP46, MTP65) were obtained from the University of Oslo,
with approval by the local ethical committee (Önnerfjord et al., 2012).
Full-depth cartilage plugs were cut into sections of 10 μm thickness
parallel to the cartilage surface starting from the superficial cartilage
using a cryotome (chamber temperature,−18 °C; blade temperature,
−21 °C). Ten consecutive sectionswere pooled. Sectionswere collected
until a depth where accurate sectioning was no longer possible,
presumably when reaching calcified tissue. Sample processing differed
slightly between the LTP and the MTP samples due to optimization of
the procedure (for detailed description of sample preparation, see
Fig. 2). Initial experiments using Tissue Tek embedding of the tissue
sample gave satisfactory results. These samples, however, had a tenden-
cy to clog the chromatographic system, most likely due to precipitation
44 C. Müller et al. / Matrix Biology 40 (2014) 34–45of residual Tissue Tek components. These problems were avoided by
removing Tissue Tek embedding from the protocol in later experiments.
It should be stressed that the focus of the study was to analyze
protein distribution patterns within a certain specimen and then to
compare these patterns in the different samples. This required constant
section areas from top to bottom throughout a given sample, but made
the different areas of the different samples irrelevant.
LTP52 sections were collected in the inner lid of an upside down-
placed filter tube (0.45 μm filter; Pall). Extraction was done for 24 h
under gentle shaking at 4 °C in the lid of the filter tubes with 150 μl of
chaotropic extraction buffer (4 M guanidine hydrochloride, 50 mM
sodium acetate, 100 mM 6-aminocaproic acid, 5 mM benzamidine,
5mMN-ethylmaleimide; pH 5.8). The extract was obtained by centrifu-
gation through the filter at 14000 × g for 3 min. Sections from the MTP
samples were collected directly into centrifuge tubes and extracted as
described above. Extracts were separated from extraction residues by
centrifugation.
4.2.2. Preparation for non-targeted quantitative mass spectrometry
In a discovery approach, the LTP52 sample was analyzed using
the iTRAQ mass spectrometry approach (Ross et al., 2004). Reduction,
alkylation and ethanol precipitation were performed as described
before (Önnerfjord et al., 2012). Samples were suspended in 100 μl
0.1 mM triethylammonium bicarbonate buffer, pH 8.5, before
trypsination with 1 μg of trypsin at +37 °C on a shaker for about 16 h.
The 24 depth fractions were collected into nine pools (Fig. 2). For this,
equal sample amounts from the individual trypsin digests (one fraction
representing the extract of 10 tissue sections representing a total
depth of 100 μm) were mixed to achieve a volume of 20 μl, thereby
representing each sample fraction equally. To achieve a better re-
solution in the uppermost and lowest layers, the extracts of fraction 1,
2, 23 and 24 were not pooled with others. Three pools formed a sample
set: set 1 (pools 1, 2 and3), set 2 (pools 4, 5 and6) and set 3 (pools 7,
8 and 9). With the iTRAQ technology, samples are labeled at the N-
terminus with isobaric labels (label 114, 115 and 116), thereby giving
the samemass adduct to all peptides, regardless of their origin. Labeled
samples are mixed with a reference sample (label 117) as used in the
study by Önnerfjord et al. (2012).
4.2.3. Preparation for targeted mass spectrometry
Sampleswere digestedwith trypsin as described above, and aliquots
of 10 μl of the trypsin digest (from selected 100 μm pools) were diluted
to 200 μl with 0.5 M ammonium bicarbonate and filtered through a
30 kDa filter. The high salt content was employed to minimize ionic
interactions between positively charged tryptic peptides from ECM
proteins and negatively charged glycosaminoglycans present in the
sample. In brief, diluted digests were centrifuged at 2060 × g for 8 min
through the filter followed by an additional wash with 100 μl 0.5 mM
ammonium bicarbonate. Before injection into the mass spectrometer,
salts were removed from the filtrates using reversed-phase C18 spin
columns according to the manufacturer's instructions.
4.3. MRM assay generation
To generate protein-specific MRM assays, in silico trypsin digestion
of proteins of interest was performed on 29 cartilage ECM proteins to
identify proteotypic peptides for each protein (Fusaro et al., 2009).
The following parameters were considered for peptide selection
(i) unique peptides, (ii) peptides shorter than 20 amino acids, (iii) no
missed cleavages, (iv) favoured y-ions over b-ions, (v) favoured
Q3 N Q1 and (vi) Q1/Q3 ratio between 400 and 1500 m/z (Q1: peptide
precursor ionmass, Q3: its specific fragment ionmass).We additionally
used representative cartilage samples to select the final peptide list.
Instrument parameters were then optimized for the highest sensitivity
for all peptides and their transitions by using purchased crude synthetic
peptides (JPT and Thermo). The measured peptide transitions are listedin Supplementary Table S3. Three to six transitions for each peptide
were measured in a scheduled MRMmethod.
4.4. LC-MS setup and analysis
For the iTRAQ approach, the procedure was as previously described
(Önnerfjord et al., 2012).
For the MRM samples, aliquots were injected and quantified using a
TSQ Vantage triple quadrupole mass spectrometer (Thermo Scientific,
Waltham MA) equipped with an Easy nano-LC system (Thermo Scien-
tific, Waltham MA). The mass spectrometer was operated in MRM
mode, with bothQ1 andQ3 settings at 0.7 Da resolution. A spray voltage
of +1700 V was used with a heated ion transfer setting of 270 °C for
desolvation. Data were acquired using the Xcalibur software (version
2.1). Mobile phases used were A (0.1% formic acid in water) and B
(0.1% formic acid in 100% acetonitrile). Separation was performed on
10 μm tip; 75 μm × 15 cm capillary columns (PicoTip™ emitter; New
Objective, Woburn, MA) packed with Reprosil-Pur C18-AQ resin
(3 μm, Dr. Maich GmbH). Samples were injected (2–4 μl) in duplicates,
except for MTP46 due to technical reasons. The on-line reversed-phase
separation was performed using a flow rate of 300 nl/min and a linear
binary gradient from 3% B for 5 min to 15% B in 3 min, then to 35% B
in 32 min and finally to 90% B in 3 min followed by a wash for 3 min
with 90% B, and reconditioning to initial conditions in 10 min. A
standard mixture of tryptic peptides was run to check the system
performance of the LC-MS setup (Teleman et al., 2012).
4.5. Data analysis
For the iTRAQ discovery approach, data analysis was done as
previously described (Önnerfjord et al., 2012).
The targetedMRMdata was analyzed using the Skyline 1.4 software
(MacCoss Lab Software, University of Washington; MacLean et al.,
2010). The relative signal from the individual transitions in combination
with the expected retention time of the peak ensured the identity of the
peak as measured by synthetic peptides during optimization. For
simplicity reasons, the summed area of the individual transitions are
presented in the selected figures throughout this paper.
We have used relative quantification in both approaches and not
absolute values, i.e. the protein distribution patterns can be compared,
but not the levels of different proteins. For clarity, values are presented
normalized to 1 (maximum relative abundance) in the graphs.
The aggrecan core protein was analyzed individually for its three
globular domains (G1, G2 and G3) to investigate differences in domain
distribution with cartilage depth. Similarly, the cartilage intermediate
layer proteins CILP 1 and CILP 2 were divided into their polypeptides
CILP 1-1, 1-2, 2-1 and 2-2 for separate analysis (Lorenzo et al., 1998a;
Lorenzo et al., 1998b; Johnson et al., 2003; Bernardo et al., 2011).
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